Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Underutilization of antiplatelet and statin therapy after postoperative myocardial infarction following vascular surgery.

Steely AM, Callas PW, Hohl PK, Schneider DJ, De Martino RR, Bertges DJ.

J Vasc Surg. 2018 Jan;67(1):279-286.e2. doi: 10.1016/j.jvs.2017.06.093. Epub 2017 Aug 19.

PMID:
28830706
2.

Major adverse cardiac events among postpercutaneous coronary intervention patients on clopidogrel and proton pump inhibitors.

Ching GG, Li D, Baker WL, Hohl PK, Mather JF, McKay RG, Lundbye JB.

Conn Med. 2012 Apr;76(4):205-11.

PMID:
22611719
3.

Legionella bozemanii, an elusive agent of fatal cavitary pneumonia.

Widmer A, Hohl P, Dirnhofer S, Bassetti S, Marsch S, Frei R.

Infection. 2007 Jun;35(3):180-1.

PMID:
17565460
5.

The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections.

Pallares R, Capdevila O, Liñares J, Grau I, Onaga H, Tubau F, Schulze MH, Hohl P, Gudiol F.

Am J Med. 2002 Aug 1;113(2):120-6.

PMID:
12133750
6.

Escherichia coli producing a cephamycinase (CMY-2) from a patient from the Libyan---Tunisian border region.

Bauernfeind A, Hohl P, Schneider I, Jungwirth R, Frei R.

Clin Microbiol Infect. 1998 Mar;4(3):168-170. No abstract available.

7.

BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis.

Entenza JM, Hohl P, Heinze-Krauss I, Glauser MP, Moreillon P.

Antimicrob Agents Chemother. 2002 Jan;46(1):171-7.

8.

In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.

Hebeisen P, Heinze-Krauss I, Angehrn P, Hohl P, Page MG, Then RL.

Antimicrob Agents Chemother. 2001 Mar;45(3):825-36.

9.

Cefetamet pivoxil in the treatment of uncomplicated gonorrhea.

Lucena R, Borges CE, Vieiralves LF, Kanga JM, Hohl P, Zappelini M, Kissling M.

Diagn Microbiol Infect Dis. 1994 Jun;19(2):121-7.

PMID:
7805356
11.

In vitro activities of Ro 40-6890 against 164 predominantly intestinal members of the families Enterobacteriaceae and Vibrionaceae.

Hohl P, Zollinger-Iten J, von Graevenitz A.

Antimicrob Agents Chemother. 1992 Dec;36(12):2835-8.

12.

Antibacterial properties of Ro 40-6890, a broad-spectrum cephalosporin, and its novel orally absorbable ester, Ro 41-3399.

Angehrn P, Hohl P, Hubschwerlen C, Page M, Then R.

Antimicrob Agents Chemother. 1992 Dec;36(12):2825-34.

13.

[Rubella epidemiology in military recruit schools].

Matter L, Hohl P, Abelin T, Schopfer K.

Schweiz Med Wochenschr. 1992 Oct 24;122(43):1606-13. German.

PMID:
1439681
15.

Six cases of travel-associated Legionnaires' disease in Ischia involving four countries.

Castellani Pastoris M, Benedetti P, Greco D, Volpi E, Billo N, Fehrenbach FJ, Hohl P, Horbach I, Wewalka G.

Infection. 1992 Mar-Apr;20(2):73-7.

PMID:
1582687
19.
20.
21.

[Epidemiology of legionnaires' disease in Switzerland in 1988].

Billo NE, Hohl PE, Winteler S.

Schweiz Med Wochenschr. 1989 Dec 23;119(51):1859-61. German.

PMID:
2692149
22.

Cefetamet pivoxil (Ro 15-8075) and amoxicillin in the treatment of bacterial exacerbations of chronic bronchial disease--preliminary results.

Medici TC, Hohl P, Wehrli R, Germano G.

J Chemother. 1989 Jul;1(4 Suppl):778-9. No abstract available.

PMID:
16312635
23.
24.

In vitro activity of cefteram against predominantly enteropathogenic and glucose nonfermentative gram-negatives.

Hohl P, von Graevenitz A, Zollinger-Iten J.

Chemotherapy. 1989;35(4):242-5.

PMID:
2766865
25.
26.
27.

Comparative in-vitro activity of fleroxacin and other 6-fluoroquinolones against mycobacteria.

Salfinger M, Hohl P, Kafader FM.

J Antimicrob Chemother. 1988 Oct;22 Suppl D:55-63.

PMID:
3144550
28.

Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxacin.

Paganoni R, Herzog C, Braunsteiner A, Hohl P.

J Antimicrob Chemother. 1988 Oct;22 Suppl D:3-17.

PMID:
3144545
29.

Cefetamet pivoxil: bacteriostatic and bactericidal activity of the free acid against 355 gram-negative rods.

Hohl P, von Graevenitz A, Zollinger-Iten J.

Infection. 1988 May-Jun;16(3):194-8.

PMID:
3403040
30.
31.
32.

In vitro activity of RO 19-5247 (T-2525) against intestinal pathogens, glucose non-fermentative gram-negative rods, Legionella and Serratia.

Hohl P, Von Graevenitz A, Zollinger-Iten J.

Chemioterapia. 1987 Jun;6(2 Suppl):98-101. No abstract available.

PMID:
3509545
33.

Infections due to Wangiella dermatitidis in humans: report of the first documented case from the United States and a review of the literature.

Hohl PE, Holley HP Jr, Prevost E, Ajello L, Padhye AA.

Rev Infect Dis. 1983 Sep-Oct;5(5):854-64.

PMID:
6635425
34.

Cystic chromomycosis caused by Wangiella dermatitidis.

Hohl P.

Arch Dermatol. 1980 Sep;116(9):987-8. No abstract available.

PMID:
7416769
35.

Asphyxia caused by laryngeal impaction of an esophageal polyp.

Cochet B, Hohl P, Sans M, Cox JN.

Arch Otolaryngol. 1980 Mar;106(3):176-8.

PMID:
7356440
36.

[The re-emergence of human rabies in Switzerland. A case history].

Hohl P, Burger R, Vorburger C, Steck F.

Schweiz Med Wochenschr. 1978 Apr 22;108(16):589-92. German.

PMID:
644275

Supplemental Content

Support Center